logo-loader
viewEve Investments Ltd

EVE Investments seeing momentum for pre-meal drink in China

The company has two investment partners, Meluka Honey and Omni Innovation.

china flag with tall buildings in background
Omni Innovation is focused on medical nutrition products for people living with disease

EVE Investments Ltd (ASX:EVE) is witnessing traction for a medical technology company that it has a 38% interest in named Omni Innovation.

Omni Innovation has a licence agreement with Eagle Health for the manufacture and distribution of Hutang-1, a pre-meal drink for people with type II diabetes and pre-diabetes.

During the March quarter, Hutang-1 increased its reach to over 80,000 consumers, including over 24,000 diabetes or pre-diabetes patients and showed promising conversion to sales.

Four stores in China

This commercial roll-out is being conducted with four dedicated retail stores in Xiamen, China and a direct community outreach program.

Eagle Health are scaling up more specialty stores beyond Xiamen and into other Chinese regions in the current June quarter and expect the trend in traffic and sales conversion to further increase.

A company focused on medical technology investment

EVE is an ASX listed investment company focused on investing in medical technology companies.

It has a preference for Australian based companies that have global scale and to date has two investment partners, Meluka Honey and Omni Innovation.

Quick facts: Eve Investments Ltd

Price: 0.0065 AUD

ASX:EVE
Market: ASX
Market Cap: $16.59 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Bull, Bears & Brokers: Shaw and Partner’s Davide Bosio talks about market...

Shaw and Partners WA state manager Davide Bosio updates Proactive on how share prices plunged this week, with stock market jitters in light of the coronavirus scare. Bosio gives his advice on how investors can protect their portfolios and takes a look at solid investment options during times...

2 hours, 57 minutes ago

2 min read